Angeliki Asimaki, a 45-year-old woman with two congenital heart defects, has been battling life-threatening heart conditions since she was 15 years old. Her symptoms began with dizziness and lightheadedness, culminating in a stroke she suffered at the age of 26. Despite enduring nine medical interventions—including open-heart surgery—she has faced immense challenges, including restrictions on her physical activities like running for a bus or climbing stairs. These difficulties fueled her determination to contribute to heart health research.

Residing in London but originally from Athens, Greece, Asimaki has channeled her struggles into groundbreaking scientific work. Funded by the British Heart Foundation, she has developed a new diagnostic method involving a simple cheek swab that detects arrhythmogenic cardiomyopathy (ACM), a condition associated with a high risk of sudden cardiac death. Her research aims not only to better understand ACM but to improve outcomes for patients at risk of similar heart conditions.

Asimaki’s story emphasizes the intersection of personal struggle and professional dedication. Her experience with congenital heart defects has not only shaped her life but has also driven her commitment to advancing heart health research. Through her work, she hopes to make a significant impact on the lives of those with similar cardiac challenges, exemplifying how adversity can lead to innovation in the medical field.